应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CRBU Caribou Biosciences
盘前交易 11-18 09:12:51 EST
1.99
-0.10
-4.78%
盘前
2.03
+0.04
+1.97%
08:58 EST
最高
2.12
最低
1.97
成交量
172.58万
今开
2.12
昨收
2.09
日振幅
7.18%
总市值
1.80亿
流通市值
1.62亿
总股本
9,055万
成交额
346.63万
换手率
2.12%
流通股本
8,158万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Caribou Biosciences, Inc.盘中异动 临近收盘股价大跌5.12%
市场透视 · 11-14
Caribou Biosciences, Inc.盘中异动 临近收盘股价大跌5.12%
Caribou Biosciences, Inc.盘中异动 股价大跌5.38%
市场透视 · 11-12
Caribou Biosciences, Inc.盘中异动 股价大跌5.38%
Caribou Biosciences, Inc.2024财年第三财季实现净利润-34.68百万美元,同比减少246.80%
市场透视 · 11-11
Caribou Biosciences, Inc.2024财年第三财季实现净利润-34.68百万美元,同比减少246.80%
Caribou Biosciences, Inc.盘中异动 股价大涨5.04%
市场透视 · 11-08
Caribou Biosciences, Inc.盘中异动 股价大涨5.04%
Caribou Biosciences, Inc.盘中异动 快速拉升5.13%
市场透视 · 11-05
Caribou Biosciences, Inc.盘中异动 快速拉升5.13%
Caribou Biosciences, Inc.盘中异动 早盘快速跳水5.88%
市场透视 · 11-04
Caribou Biosciences, Inc.盘中异动 早盘快速跳水5.88%
Caribou Biosciences, Inc.盘中异动 早盘急速拉升5.24%报2.06美元
市场透视 · 11-01
Caribou Biosciences, Inc.盘中异动 早盘急速拉升5.24%报2.06美元
Caribou Biosciences, Inc.盘中异动 快速跳水5.33%报1.87美元
市场透视 · 10-31
Caribou Biosciences, Inc.盘中异动 快速跳水5.33%报1.87美元
Caribou Biosciences, Inc.盘中异动 股价大涨5.18%报2.03美元
市场透视 · 10-30
Caribou Biosciences, Inc.盘中异动 股价大涨5.18%报2.03美元
Caribou Biosciences, Inc.盘中异动 早盘大幅上涨5.08%报1.86美元
市场透视 · 10-28
Caribou Biosciences, Inc.盘中异动 早盘大幅上涨5.08%报1.86美元
Caribou Biosciences, Inc.盘中异动 大幅跳水5.21%报1.82美元
市场透视 · 10-25
Caribou Biosciences, Inc.盘中异动 大幅跳水5.21%报1.82美元
Caribou Biosciences, Inc.盘中异动 急速下跌5.10%报1.96美元
市场透视 · 10-17
Caribou Biosciences, Inc.盘中异动 急速下跌5.10%报1.96美元
Caribou Biosciences, Inc.盘中异动 大幅拉升5.13%报2.05美元
市场透视 · 10-16
Caribou Biosciences, Inc.盘中异动 大幅拉升5.13%报2.05美元
Caribou Biosciences, Inc.盘中异动 股价大涨5.00%报2.00美元
市场透视 · 10-15
Caribou Biosciences, Inc.盘中异动 股价大涨5.00%报2.00美元
Caribou Biosciences, Inc.盘中异动 下午盘大幅上涨5.00%报1.89美元
市场透视 · 10-12
Caribou Biosciences, Inc.盘中异动 下午盘大幅上涨5.00%报1.89美元
Caribou Biosciences, Inc.盘中异动 急速上涨5.04%
市场透视 · 10-08
Caribou Biosciences, Inc.盘中异动 急速上涨5.04%
Caribou Biosciences, Inc.盘中异动 下午盘急速拉升5.03%报1.88美元
市场透视 · 10-05
Caribou Biosciences, Inc.盘中异动 下午盘急速拉升5.03%报1.88美元
Caribou Biosciences, Inc.盘中异动 早盘快速下挫5.10%
市场透视 · 10-01
Caribou Biosciences, Inc.盘中异动 早盘快速下挫5.10%
Caribou Biosciences, Inc.盘中异动 下午盘快速拉升5.00%
市场透视 · 09-19
Caribou Biosciences, Inc.盘中异动 下午盘快速拉升5.00%
Caribou Biosciences, Inc.盘中异动 早盘股价大涨5.17%报2.14美元
市场透视 · 09-13
Caribou Biosciences, Inc.盘中异动 早盘股价大涨5.17%报2.14美元
加载更多
公司概况
公司名称:
Caribou Biosciences
所属市场:
NASDAQ
上市日期:
--
主营业务:
Caribou Biosciences, Inc.于2011年10月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,致力于通过应用该公司的新型CRISPR平台、CRISPR混合RNA-DNA或chRDNA来开发下一代基因组编辑细胞疗法,从而改变患有毁灭性疾病的患者的生活。
发行价格:
--
{"stockData":{"symbol":"CRBU","market":"US","secType":"STK","nameCN":"Caribou Biosciences","latestPrice":1.99,"timestamp":1731704400000,"preClose":2.09,"halted":0,"volume":1725798,"hourTrading":{"tag":"盘前","latestPrice":2.0293,"preClose":1.99,"latestTime":"08:58 EST","volume":4369,"amount":8830.5725565,"timestamp":1731938331732},"delay":0,"floatShares":81578752,"shares":90552687,"eps":-1.651751,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.1,"latestTime":"11-18 09:12:51 EST","open":2.12,"high":2.12,"low":1.97,"amount":3466282.3684002,"amplitude":0.07177,"askPrice":2.03,"askSize":50,"bidPrice":1.84,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.651751,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731940200000},"adr":0,"listingDate":1627012800000,"adjPreClose":1.99,"preHourTrading":{"tag":"盘前","latestPrice":2.0293,"preClose":1.99,"latestTime":"08:58 EST","volume":4369,"amount":8830.5725565,"timestamp":1731938331732},"postHourTrading":{"tag":"盘后","latestPrice":2.03,"preClose":1.99,"latestTime":"19:09 EST","volume":16340,"amount":32526.0588,"timestamp":1731715747115},"volumeRatio":0.9664905210614966,"impliedVol":0.5364,"impliedVolPercentile":0.136},"requestUrl":"/m/hq/s/CRBU","defaultTab":"news","newsList":[{"id":"2483850087","title":"Caribou Biosciences, Inc.盘中异动 临近收盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483850087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483850087?lang=zh_cn&edition=full","pubTime":"2024-11-14 04:46","pubTimestamp":1731530793,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日04时46分,Caribou Biosciences, Inc.股票出现波动,股价急速下挫5.12%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.49%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114044633a2350453&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114044633a2350453&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","CRBU"],"gpt_icon":0},{"id":"2482423085","title":"Caribou Biosciences, Inc.盘中异动 股价大跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482423085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482423085?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:31","pubTimestamp":1731421896,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时31分,Caribou Biosciences, Inc.股票出现异动,股价大幅下挫5.38%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.10%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223136971a5fd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223136971a5fd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CRBU"],"gpt_icon":0},{"id":"2482262071","title":"Caribou Biosciences, Inc.2024财年第三财季实现净利润-34.68百万美元,同比减少246.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482262071","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482262071?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:00","pubTimestamp":1731254427,"startTime":"0","endTime":"0","summary":"11月11日,Caribou Biosciences, Inc.公布财报,公告显示公司2024财年第三财季净利润为-34.68百万美元,同比减少246.80%;其中营业收入为2.02百万美元,同比减少91.46%,每股基本收益为-0.38美元。从资产负债表来看,Caribou Biosciences, Inc.总负债63.13百万美元,其中短期债务1.19百万美元,资产负债比为0.06,流动比率为0.08。机构评级:截至2024年11月11日,当前有8家机构对Caribou Biosciences, Inc.目标价做出预测,其中目标均价为15.50美元,其中最低目标价为3.00美元,最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000036abb36229&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000036abb36229&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU"],"gpt_icon":0},{"id":"2481488437","title":"Caribou Biosciences, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481488437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481488437?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:32","pubTimestamp":1731079923,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时32分,Caribou Biosciences, Inc.股票出现波动,股价快速上涨5.04%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.78%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110823320398e41844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110823320398e41844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBU","BK4539"],"gpt_icon":0},{"id":"2481685377","title":"Caribou Biosciences, Inc.盘中异动 快速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481685377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481685377?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:55","pubTimestamp":1730818501,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时55分,Caribou Biosciences, Inc.股票出现异动,股价快速上涨5.13%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.67%。其相关个股中,Bionomics Ltd Ads Each Rep 180 Ord Shs、Zyversa Therapeutics, Inc.、Nutriband Inc C/Wts 涨幅较大,Zyversa Therapeutics, Inc.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Elevai Labs, Inc.较为活跃,换手率分别为4292.51%、1410.33%、495.58%,振幅较大的相关个股有Bionomics Ltd Ads Each Rep 180 Ord Shs、Zyversa Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为67.30%、42.31%、29.27%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105225502971a4737&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105225502971a4737&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBU","BK4539"],"gpt_icon":0},{"id":"2480584286","title":"Caribou Biosciences, Inc.盘中异动 早盘快速跳水5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480584286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480584286?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:43","pubTimestamp":1730731399,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时43分,Caribou Biosciences, Inc.股票出现异动,股价急速下挫5.88%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.22%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104224319971a42a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104224319971a42a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBU","BK4539"],"gpt_icon":0},{"id":"2480889338","title":"Caribou Biosciences, Inc.盘中异动 早盘急速拉升5.24%报2.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480889338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480889338?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:31","pubTimestamp":1730467860,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时31分,Caribou Biosciences, Inc.股票出现异动,股价急速拉升5.24%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101213101ab92b4d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101213101ab92b4d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CRBU"],"gpt_icon":0},{"id":"2479331340","title":"Caribou Biosciences, Inc.盘中异动 快速跳水5.33%报1.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479331340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479331340?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:49","pubTimestamp":1730382577,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时49分,Caribou Biosciences, Inc.股票出现波动,股价快速下挫5.33%。截至发稿,该股报1.87美元/股,成交量7.5329万股,换手率0.08%,振幅5.08%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为2.37%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121493798e3fb90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121493798e3fb90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4539","BK4139"],"gpt_icon":0},{"id":"2479786952","title":"Caribou Biosciences, Inc.盘中异动 股价大涨5.18%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479786952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479786952?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:56","pubTimestamp":1730296594,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时56分,Caribou Biosciences, Inc.股票出现异动,股价急速上涨5.18%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.32%。其相关个股中,Tharimmune, Inc.、Ensysce Biosciences, Inc.、Quince Therapeutics, Inc.涨幅较大,Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm Plc较为活跃,换手率分别为3042.91%、581.39%、42.73%,振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Quince Therapeutics, Inc.,振幅分别为70.94%、52.36%、35.76%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030215635ab846407&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030215635ab846407&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBU","BK4539"],"gpt_icon":0},{"id":"2478864104","title":"Caribou Biosciences, Inc.盘中异动 早盘大幅上涨5.08%报1.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478864104","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478864104?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:40","pubTimestamp":1730122840,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时40分,Caribou Biosciences, Inc.股票出现异动,股价大幅拉升5.08%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.34%。其相关个股中,Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Tc Biopharm Plc、Viracta Therapeutics, Inc.、Immunoprecise Antibodies Ltd.较为活跃,换手率分别为552.64%、49.02%、37.93%,振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Monte Rosa Therapeutics, Inc.、Monopar Therapeutics Inc.,振幅分别为45.41%、20.45%、18.55%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214040ab7bc8eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214040ab7bc8eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBU","BK4539"],"gpt_icon":0},{"id":"2478669214","title":"Caribou Biosciences, Inc.盘中异动 大幅跳水5.21%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478669214","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478669214?lang=zh_cn&edition=full","pubTime":"2024-10-25 02:30","pubTimestamp":1729794625,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日02时30分,Caribou Biosciences, Inc.股票出现波动,股价快速下挫5.21%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.26%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025023025971a220c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025023025971a220c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CRBU"],"gpt_icon":0},{"id":"2476712021","title":"Caribou Biosciences, Inc.盘中异动 急速下跌5.10%报1.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476712021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476712021?lang=zh_cn&edition=full","pubTime":"2024-10-17 22:38","pubTimestamp":1729175916,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日22时38分,Caribou Biosciences, Inc.股票出现波动,股价急速跳水5.10%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.79%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017223836971a0dda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017223836971a0dda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4539","BK4139"],"gpt_icon":0},{"id":"2475916857","title":"Caribou Biosciences, Inc.盘中异动 大幅拉升5.13%报2.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475916857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475916857?lang=zh_cn&edition=full","pubTime":"2024-10-16 22:17","pubTimestamp":1729088245,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日22时17分,Caribou Biosciences, Inc.股票出现波动,股价快速拉升5.13%。截至发稿,该股报2.05美元/股,成交量19.8692万股,换手率0.22%,振幅4.62%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.31%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016221725971a0a52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016221725971a0a52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CRBU"],"gpt_icon":0},{"id":"2475450639","title":"Caribou Biosciences, Inc.盘中异动 股价大涨5.00%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475450639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475450639?lang=zh_cn&edition=full","pubTime":"2024-10-15 23:34","pubTimestamp":1729006457,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日23时34分,Caribou Biosciences, Inc.股票出现波动,股价快速上涨5.00%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.18%。其相关个股中,Bright Minds Biosciences Inc.、Apollomics Inc C/Wts 01/04/2028 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Bright Minds Biosciences Inc.、Lipella Pharmaceuticals Inc.、Gritstone Bio, Inc.较为活跃,换手率分别为1285.94%、326.89%、226.33%,振幅较大的相关个股有Bright Minds Biosciences Inc.、Apollomics Inc C/Wts 01/04/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为587.55%、123.44%、93.62%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101523341798e3c958&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101523341798e3c958&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBU","BK4539"],"gpt_icon":0},{"id":"2474101960","title":"Caribou Biosciences, Inc.盘中异动 下午盘大幅上涨5.00%报1.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474101960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474101960?lang=zh_cn&edition=full","pubTime":"2024-10-12 01:30","pubTimestamp":1728667802,"startTime":"0","endTime":"0","summary":"北京时间2024年10月12日01时30分,Caribou Biosciences, Inc.股票出现异动,股价大幅拉升5.00%。截至发稿,该股报1.89美元/股,成交量28.2698万股,换手率0.31%,振幅5.85%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为1.27%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410120130029719fbbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410120130029719fbbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"gpt_icon":0},{"id":"2473039476","title":"Caribou Biosciences, Inc.盘中异动 急速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473039476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473039476?lang=zh_cn&edition=full","pubTime":"2024-10-08 22:01","pubTimestamp":1728396090,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日22时01分,Caribou Biosciences, Inc.股票出现波动,股价快速拉升5.04%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.05%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100822013098e3b2fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100822013098e3b2fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"gpt_icon":0},{"id":"2473967232","title":"Caribou Biosciences, Inc.盘中异动 下午盘急速拉升5.03%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473967232","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473967232?lang=zh_cn&edition=full","pubTime":"2024-10-05 01:04","pubTimestamp":1728061450,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日01时04分,Caribou Biosciences, Inc.股票出现波动,股价快速拉升5.03%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241005010411ab67c1bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241005010411ab67c1bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4139","BK4539"],"gpt_icon":0},{"id":"2472164377","title":"Caribou Biosciences, Inc.盘中异动 早盘快速下挫5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472164377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472164377?lang=zh_cn&edition=full","pubTime":"2024-10-01 23:05","pubTimestamp":1727795110,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日23时05分,Caribou Biosciences, Inc.股票出现异动,股价大幅下跌5.10%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001230511ab67530e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001230511ab67530e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"gpt_icon":0},{"id":"2468302205","title":"Caribou Biosciences, Inc.盘中异动 下午盘快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468302205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468302205?lang=zh_cn&edition=full","pubTime":"2024-09-19 02:01","pubTimestamp":1726682508,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日02时01分,Caribou Biosciences, Inc.股票出现异动,股价大幅拉升5.00%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.37%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919020149ab64660c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919020149ab64660c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"gpt_icon":0},{"id":"2467779445","title":"Caribou Biosciences, Inc.盘中异动 早盘股价大涨5.17%报2.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467779445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467779445?lang=zh_cn&edition=full","pubTime":"2024-09-13 22:29","pubTimestamp":1726237746,"startTime":"0","endTime":"0","summary":"北京时间2024年09月13日22时29分,Caribou Biosciences, Inc.股票出现波动,股价快速拉升5.17%。截至发稿,该股报2.14美元/股,成交量14.655万股,换手率0.16%,振幅3.25%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.04%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409132229069719b4f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409132229069719b4f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CRBU"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cariboubio.com","stockEarnings":[{"period":"1week","weight":-0.2575},{"period":"1month","weight":-0.034},{"period":"3month","weight":-0.0478},{"period":"6month","weight":-0.413},{"period":"1year","weight":-0.5793},{"period":"ytd","weight":-0.6527}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Caribou Biosciences, Inc.于2011年10月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,致力于通过应用该公司的新型CRISPR平台、CRISPR混合RNA-DNA或chRDNA来开发下一代基因组编辑细胞疗法,从而改变患有毁灭性疾病的患者的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":-0.023679},{"month":2,"riseRate":0.333333,"avgChangeRate":0.021713},{"month":3,"riseRate":0,"avgChangeRate":-0.186143},{"month":4,"riseRate":0,"avgChangeRate":-0.22596},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.018452},{"month":6,"riseRate":0,"avgChangeRate":-0.271659},{"month":7,"riseRate":1,"avgChangeRate":0.533932},{"month":8,"riseRate":0.5,"avgChangeRate":0.161189},{"month":9,"riseRate":0.25,"avgChangeRate":-0.083644},{"month":10,"riseRate":0,"avgChangeRate":-0.097774},{"month":11,"riseRate":0.5,"avgChangeRate":0.107258},{"month":12,"riseRate":0,"avgChangeRate":-0.179193}],"exchange":"NASDAQ","name":"Caribou Biosciences","nameEN":"Caribou Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Caribou Biosciences(CRBU)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Caribou Biosciences(CRBU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Caribou Biosciences,CRBU,Caribou Biosciences股票,Caribou Biosciences股票老虎,Caribou Biosciences股票老虎国际,Caribou Biosciences行情,Caribou Biosciences股票行情,Caribou Biosciences股价,Caribou Biosciences股市,Caribou Biosciences股票价格,Caribou Biosciences股票交易,Caribou Biosciences股票购买,Caribou Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Caribou Biosciences(CRBU)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Caribou Biosciences(CRBU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}